Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announces the completion of PatientBase's forecast period and disease indication updates. The forecast period now reflects 2008 to 2018 data. PatientBase is the premier epidemiology database for the pharmaceutical industry, providing complete coverage of more than 140 disease indications including over 711 patient populations across the G7 pharmaceutical markets (U.S., France, Germany, Italy, Spain, United Kingdom and Japan).

"In response to our clients' needs we are continuously working on updating PatientBase," stated Amanda Wilson, epidemiologist and product manager at Decision Resources. "Its rich data set and easy-to-use Web interface allows our clients to focus on the age cohort, country, disease subtype (including comorbidity), disease subpopulation segment of interest or specific years to meet their unique needs and research objectives."

PatientBase also offers treatable pools for its cancer indications. Treatable pools can be used for greater accuracy in forecasting and sizing a cancer market by taking into account both relevant patient populations and patient populations by stages.

For a complete list of updated indications, please contact Natalia Morales at nmorales@dresources.com or Elizabeth Marshall at emarshall@dresources.com.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Natalia Morales           Elizabeth Marshall   Decision Resources        Decision Resources, Inc.   781-296-2691              781-296-2563   nmorales@dresources.com   emarshall@dresources.com 

First Call Analyst:
FCMN Contact:

SOURCE: Decision Resources

CONTACT: Natalia Morales of Decision Resources, +1-781-296-2691,
nmorales@dresources.com; or Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013

View Now